The global portable patient isolation market size to cross USD 65 million by 2026, growing at a CAGR of 13% during the forecast period. The demand for transport rooms and pods is likely to observe an impetus due to increased efforts to isolate symptomatic or suspected patients suffering from COVID-19 effectively. As the world is struggling to control and prevent the spread of coronavirus, vendors engaged in manufacturing and sales of patient isolation products are witnessing a surge for these products from medical and health facilities and military, defense, and government bodies. Improvements in global healthcare infrastructure and the adoption of cost-effective, energy-efficient, and sustainable resource dependence are the other main factors driving the market.
- The portable patient isolation room segment is growing at a promising CAGR during the forecast period and is expected to add an incremental value of $17.25 million.
- APAC is expected to emerge as the fastest-growing segment for room isolation products accounting for a CAGR of 20.65%.
- Europe was the largest pods market in 2020 and is expected to reach over $13 million by 2026.
- The defense and other segments are expected to witness an absolute growth of over 120% due to the outbreak of the COVID-19 pandemic.
GLOBAL PORTABLE PATIENT ISOLATION MARKET SEGMENTATION
This research report includes a detailed segmentation by
INSIGHTS BY PRODUCT
Increased innovations in transport pods and the outbreak of infected/contagious diseases are factors responsible for adopting pods in healthcare settings. APAC is expected to grow at the fastest CAGR during the forecast period because of increased healthcare construction activities and a rise in private and public investments in the healthcare sector. However, the important factor that is likely to influence the market is introducing innovative transportation pods. Vendors offer pods with HEPA filters, while others are deploying proper ventilator hoses and well equipped with medical ports, sluice bags, gloves, and operator ports. The demand for transport pods has increased drastically with the breakout of the COVID-19 pandemic.
Treatment rooms are designed to limit the spread of pathogens and help healthcare professionals to control the outbreak of contagious diseases. With its high occupancy, treatment rooms are highly effective in preventing the spread of infectious diseases. They are a flexible, low-cost alternative to permanent isolation wards, which reduces the impact of bed blocking. Hence, treatment rooms are expected to offer an efficient isolation option for patients suffering from contagious diseases, increasing their application.
INSIGHTS BY END-USER
The demand for identification, containment, and treatment of infectious patients and the growth potential of portable patient isolation systems are likely to increase the adoption of treatment rooms and pods in the healthcare segment. The high prevalence of viral, bacterial, and antibiotic-resistance microbial infections has encouraged end-users to invest in portable pods to prevent infections acquired in hospitals. Epidemics have highlighted the importance of large-scale, portable infrastructure POC/rapid tests for public health needs and patient outcomes and fill gaps in current diagnostic testing methodologies. Therefore, the increase in the number of people suffering from infections is encouraging physicians in hospitals to portable pods, thereby contributing to the segment's growth.
In 2020, the defense end-user segment accounts for the major revenues of the portable patient isolation market share. However, other end-users, including inpatient rehabilitation centers, long-term care facilities, nursing homes, acute care facilities, and airports and train stations with cross-border movement, are likely to emerge as the major revenue contributors to the segment. Currently, the demand for pods or non-instant portable patient isolation systems is high from other end-users. Other end-users have emerged as leading buyers of portable patient isolation pods. They transport patients with infectious diseases to proper healthcare settings easily and efficiently while protecting healthcare providers and other peoples. Airports, train stations, and military bases offer high growth opportunities for portable patient isolation products.
INSIGHTS BY READINESS
Instant portable patient isolation pods and rooms can be operational in less than 15 minutes. These pods are used to shift infectious patients to medical facilities and that person with chemical, biological, pathogenic, radioactive, and nuclear contamination. These products find applications among end-users as they are more cost and space-effective than conventional and fixed isolation rooms. Non-instant isolation products have a high adoption in government and public sectors as they generally consist of multi-patient isolation products, including negative pressure and anterooms fixtures. Such products can provide effective isolation for multiple patients and can be easily dismantled and moved to another location with the spread of infections.
INSIGHTS BY GEOGRAPHY
In light of the corona pandemic outbreak, the healthcare sector is expected to emerge immune from political uncertainties prevailing over Europe post the Brexit negotiations, which are expected to affect the economic growth adversely. Vendors of portable patient isolation products have met new orders in H1 2020, despite lockdown in several countries. The increased pressure to enhance infection capabilities and control the spread of the coronavirus virus across Europe is expected to augur well for the market. Moreover, the growth of portable patient isolation products in Europe is mainly supported by growing investments and government spending on the healthcare infrastructure and preparedness to manage the second wave of the coronavirus.
INSIGHTS BY VENDORS
One of the major innovations in the market is the introduction of HEPA filters and air pressure units, capable of containing pathogens, contact, and droplet nuclei, and can generate negative and positive pressures. Vendors with better technical and financial resources can develop innovative products that could pose a threat to competitor products, making them non-competitive and even obsolete before they can recover R&D and commercialization costs. Therefore, vendors must develop new technologies and remain abreast of upcoming innovations to have a competitive advantage over other vendors.
The global portable patient isolation market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
- Defense & Others
- South Korea